Runge-Morris M A
Institute of Chemical Toxicology, Wayne State University, Detroit, Michigan 48201, USA.
FASEB J. 1997 Feb;11(2):109-17. doi: 10.1096/fasebj.11.2.9039952.
Understanding the molecular regulation of the sulfotransferases is important because these enzymes are essential to a number of critical biological processes. Sulfotransferase expression clearly plays a role in xenobiotic detoxication, carcinogen activation, prodrug processing, cellular signaling pathways, and the regulation of intratissue active androgen and estrogen levels. Although cytosolic sulfotransferases are present in the gut, adrenal, kidney, lung, skin, brain, and other extrahepatic tissues, the basis for the molecular regulation of this complicated gene family has been best characterized in the rat liver, where sulfotransferase levels are relatively abundant. Advances in genomic cloning and in the molecular characterization of individual sulfotransferase cDNAs have inspired new insights into the mechanisms involved in sulfotransferase gene regulation. In particular, the hypothalamic-pituitary-gonadal-adrenocortical axis appears to play a significant role in the regulation of individual sulfotransferase genes. The molecular signals that fluctuate with developmental age, gender, and the occurrence of systemic endocrinopathies also influence sulfotransferase gene expression. For example, diabetes, which disrupts glucose and ketone homeostasis, insulin sensitivity, gonadal and neuroendocrine hormone balance, protein kinase C isoform expression, and P450 metabolism, also disturbs hepatic sulfotransferase gene expression. What role does sulfotransferase expression play in target organ toxicity? Do xenobiotic-mediated changes in sulfotransferase expression compromise detoxication? Does deregulated sulfotransferase expression during development lead to birth defects by perturbing the delicate balance of active hormone levels in fetal tissues? Do conditions of glucocorticoid excess, such as stress or high-dose glucocorticoid therapy induce sulfotransferase expression and place toxicant and carcinogen bioactivation systems in overdrive? This review will summarize our current understanding of the molecular and cellular regulation of the major rodent cytosolic sulfotransferases. Only by thoroughly dissecting the regulation of this important multigene family in rodent liver, where sulfotransferase expression is most abundant, can we begin to focus on more pressing questions concerning the role of the sulfotransferases in the genesis of endocrinopathies and cancer in humans.
了解磺基转移酶的分子调控非常重要,因为这些酶对于许多关键的生物学过程至关重要。磺基转移酶的表达显然在异生物解毒、致癌物激活、前药加工、细胞信号通路以及组织内活性雄激素和雌激素水平的调节中发挥作用。虽然胞质磺基转移酶存在于肠道、肾上腺、肾脏、肺、皮肤、大脑和其他肝外组织中,但这个复杂基因家族分子调控的基础在大鼠肝脏中得到了最充分的表征,在那里磺基转移酶水平相对丰富。基因组克隆和单个磺基转移酶cDNA分子特征的进展激发了对磺基转移酶基因调控机制的新见解。特别是,下丘脑-垂体-性腺-肾上腺皮质轴似乎在单个磺基转移酶基因的调控中发挥重要作用。随着发育年龄、性别和全身性内分泌疾病的发生而波动的分子信号也会影响磺基转移酶基因的表达。例如,糖尿病会破坏葡萄糖和酮的稳态、胰岛素敏感性、性腺和神经内分泌激素平衡、蛋白激酶C同工型表达以及细胞色素P450代谢,也会扰乱肝脏磺基转移酶基因的表达。磺基转移酶表达在靶器官毒性中起什么作用?异生物介导的磺基转移酶表达变化是否会损害解毒作用?发育过程中磺基转移酶表达失调是否会通过扰乱胎儿组织中活性激素水平的微妙平衡而导致出生缺陷?糖皮质激素过量的情况,如应激或高剂量糖皮质激素治疗,是否会诱导磺基转移酶表达并使毒物和致癌物生物激活系统超速运转?本综述将总结我们目前对主要啮齿动物胞质磺基转移酶分子和细胞调控的理解。只有通过深入剖析这个重要的多基因家族在磺基转移酶表达最丰富的啮齿动物肝脏中的调控,我们才能开始关注关于磺基转移酶在人类内分泌疾病和癌症发生中的作用的更紧迫问题。